Literature DB >> 3261327

Mechanisms and implications of hypoalbuminemia in head-injured patients.

C J McClain1, B Hennig, L G Ott, S Goldblum, A B Young.   

Abstract

Severely head-injured patients are hypermetabolic/hypercatabolic and exhibit many aspects of the postinjury acute-phase response. These patients have hypoalbuminemia, hypozincemia, hypoferremia, hypercupria, fever, and increased synthesis of acute-phase proteins such as ceruloplasmin and higher C-reactive protein levels. It has been suggested that increased interleukin-1 (IL-1) in the ventricular fluid may be responsible, at least in part, for these metabolic abnormalities. In the present study, serum albumin levels were evaluated throughout an 18-day study period in 62 head-injured patients receiving aggressive nutritional support. Hypoalbuminemia (mean +/- standard error of the mean 3.10 +/- 0.2 gm/dl; normal value 3.5 to 5 gm/dl) was observed upon hospital admission; these albumin levels continued to decrease until 2 weeks postinjury, despite aggressive nutritional support. This hypoalbuminemia may be mediated via altered endothelial permeability properties due to endothelial cell dysfunction caused by cytokines such as IL-1. Transendothelial movement of albumin was assayed using a pulmonary artery endothelial cell culture system. Both a crude macrophage supernatant derived from a murine P388D cell line having IL-1 activity (mIL-1) and human recombinant IL-1 (rIL-1) were tested. The amount of albumin transferred was time- and concentration-dependent, with maximal transfer at 24 hours and 20 U of mIL-1 per 0.5 ml of culture medium. Endothelial permeability changes observed after incubation with mIL-1 were confirmed using rIL-1. Compared to control cultures, 20 U of rIL-1 and 20 U of mIL-1 increased albumin transfer across endothelial monolayers 205% and 459%, respectively. These findings suggest that the mechanism of hypoalbuminemia seen after severe head trauma can be explained in part by IL-1-induced endothelial cell injury, resulting in enhanced endothelial permeability to albumin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261327     DOI: 10.3171/jns.1988.69.3.0386

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Possible role of short-term parenteral nutrition with fat emulsions for development of haemophagocytosis with multiple organ failure in a patient with traumatic brain injury.

Authors:  B Roth; P O Grände; P Nilsson-Ehle; I Eliasson
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

3.  Tungsten treatment prevents tumor necrosis factor-induced injury of brain endothelial cells.

Authors:  L S Terada; I R Willingham; D M Guidot; G N Shibao; G W Kindt; J E Repine
Journal:  Inflammation       Date:  1992-02       Impact factor: 4.092

4.  A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation.

Authors:  B Asgeirsson; P O Grände; C H Nordström
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 5.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

6.  Decreased plasma protein binding of valproate in patients with acute head trauma.

Authors:  G D Anderson; B E Gidal; R J Hendryx; A B Awan; N R Temkin; A J Wilensky; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

7.  Isolated Brain Trauma in Cats Triggers Rapid Onset of Hypovolemia.

Authors:  Peter Bentzer; Per-Olof Grände
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.